Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Emicizumab in Hemophilia A: NCT06938659 Clinical Landscape Report 2026
16 September 2026
NCT06938659 clinical landscape for Hemophilia A: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Efanesoctocog alfa in Hemophilia A: NCT06940830 Clinical Landscape Report 2026
16 September 2026
NCT06940830 clinical landscape for Hemophilia A: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Efanesoctocog alfa in Hemophilia A: NCT06941870 Clinical Landscape Report 2026
16 September 2026
NCT06941870 clinical landscape for Hemophilia A: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
L-Citrulline in Vaso-occlusive crisis: NCT06989567 Clinical Landscape Report 2026
16 September 2026
NCT06989567 clinical landscape for Vaso-occlusive crisis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Rilzabrutinib in Anemia, Sickle Cell: NCT06975865 Clinical Landscape Report 2026
16 September 2026
NCT06975865 clinical landscape for Anemia, Sickle Cell: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
CS-101 in Acute Chest Syndrome: NCT07000318 Clinical Landscape Report 2026
16 September 2026
NCT07000318 clinical landscape for Acute Chest Syndrome: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Deferasirox in Complication: NCT07023666 Clinical Landscape Report 2026
16 September 2026
NCT07023666 clinical landscape for Complication: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
I-131-Apamistamab in Hemoglobin SC Disease: NCT07015684 Clinical Landscape Report 2026
16 September 2026
NCT07015684 clinical landscape for Hemoglobin SC Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
ENTR-601-45 in Muscular Dystrophy, Duchenne: NCT07038824 Clinical Landscape Report 2026
16 September 2026
NCT07038824 clinical landscape for Muscular Dystrophy, Duchenne: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
ENTR-601-44 in Exon 44 Skipping Mutation Duchenne Muscular Dystrophy: NCT07037862 Clinical Landscape Report 2026
16 September 2026
NCT07037862 clinical landscape for Exon 44 Skipping Mutation Duchenne Muscular Dystrophy: endpoints, sponsor, phase, geography, readouts, asset context and d…
9 min read
Etavopivat in Thalassemia: NCT07023029 Clinical Landscape Report 2026
16 September 2026
NCT07023029 clinical landscape for Thalassemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
BBM-D101 in Muscular Dystrophy, Duchenne: NCT07058662 Clinical Landscape Report 2026
16 September 2026
NCT07058662 clinical landscape for Muscular Dystrophy, Duchenne: endpoints, sponsor, phase, geography, readouts, asset context and development white space.